메뉴 건너뛰기




Volumn 4, Issue 1, 2012, Pages

Infectious complications in chronic lymphocytic leukemia

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALEMTUZUMAB; ALKYLATING AGENT; BENDAMUSTINE; CHLORAMBUCIL; CLADRIBINE; COMPLEMENT; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; FLUDARABINE; GANCICLOVIR; IMMUNOGLOBULIN; OFATUMUMAB; PREDNISONE; RITUXIMAB;

EID: 84875995562     PISSN: None     EISSN: 20353006     Source Type: Journal    
DOI: 10.4084/MJHID.2012.070     Document Type: Review
Times cited : (57)

References (62)
  • 1
    • 0023092276 scopus 로고
    • Prognosis of chronic lymphocytic leukemia: a multivariate regression analysis of 325 untreated patients
    • PMid:3814821
    • Lee JS, Dixon D, Kantarjian H, Keating MJ, Talpaz P. Prognosis of chronic lymphocytic leukemia: a multivariate regression analysis of 325 untreated patients. Blood 1987; 69: 929-936 PMid:3814821
    • (1987) Blood , vol.69 , pp. 929-936
    • Lee, J.S.1    Dixon, D.2    Kantarjian, H.3    Keating, M.J.4    Talpaz, P.5
  • 2
    • 0028345579 scopus 로고
    • Infections in chronic lymphocytic leukemia risks factors and impact on survival and treatment
    • PMid:8049645
    • Molica S. Infections in chronic lymphocytic leukemia risks factors and impact on survival and treatment. Leuk Lymphoma 1994; 13: 203-214 http://dx.doi.org/10.3109/10428199409056283 PMid:8049645
    • (1994) Leuk Lymphoma , vol.13 , pp. 203-214
    • Molica, S.1
  • 3
    • 0023092276 scopus 로고
    • Prognosis of chronic lymphocytic leukemia a multivariate regression analysis of 325 untreated patients
    • PMid:3814821
    • Lee JS, Dixon D, Kantarjian H, Keating MJ and Talpaz P. Prognosis of chronic lymphocytic leukemia a multivariate regression analysis of 325 untreated patients Blood 1987; 69 929-936 PMid:3814821
    • (1987) Blood , vol.69 , pp. 929-936
    • Lee, J.S.1    Dixon, D.2    Kantarjian, H.3    Keating, M.J.4    Talpaz, P.5
  • 4
    • 0030927872 scopus 로고    scopus 로고
    • Prophylactic strategies to meet infectious complications in fludarabine-treated CLL
    • PMid:9179282
    • Sudhoff T, Arning M and Schneider W. Prophylactic strategies to meet infectious complications in fludarabine-treated CLL. Leukemia 1997; 11: suppl. 2, S38-S41 PMid:9179282
    • (1997) Leukemia , vol.11 , Issue.SUPPL. 2
    • Sudhoff, T.1    Arning, M.2    Schneider, W.3
  • 5
    • 0031952390 scopus 로고    scopus 로고
    • The infectious complications of Chronic Lymphocytic Leukemia
    • PMid:9625391
    • Morrison VA. The infectious complications of Chronic Lymphocytic Leukemia. Sem Oncol 1998; 25: 98-106 PMid:9625391
    • (1998) Sem Oncol , vol.25 , pp. 98-106
    • Morrison, V.A.1
  • 6
    • 28044461775 scopus 로고    scopus 로고
    • Intracerebral CSF collection mimicking cerebral abscess in a patient suffering from cryptococcal meningitis
    • PMid:16291277
    • Vakis A, Koutentakis D, Karabetsos D, Ntouros D. Intracerebral CSF collection mimicking cerebral abscess in a patient suffering from cryptococcal meningitis. J Infect 2005; 51: e233-235 http://dx.doi.org/10.1016/j.jinf.2005.02.007 PMid:16291277
    • (2005) J Infect , vol.51
    • Vakis, A.1    Koutentakis, D.2    Karabetsos, D.3    Ntouros, D.4
  • 9
    • 81255171499 scopus 로고    scopus 로고
    • Epidemiological trends in invasive aspergillosis in France the SAIF network (2005-2007)
    • PMid:21668573
    • Lortholary O, Gangneux J-P, Sitbon K, Lebeau B, de Mombrison F, Le Strat Y et al. Epidemiological trends in invasive aspergillosis in France the SAIF network (2005-2007). Clin Microbiol Infect 2011; 17:1882-1889 http://dx.doi.org/10.1111/j.1469-0691.2011.03548.x PMid:21668573
    • (2011) Clin Microbiol Infect , vol.17 , pp. 1882-1889
    • Lortholary, O.1    Gangneux, J.-P.2    Sitbon, K.3    Lebeau, B.4    de Mombrison, F.5    Le Strat, Y.6
  • 10
    • 78249285274 scopus 로고    scopus 로고
    • The Nationwide Austrian Aspergillus Registry: a prospective data collection on epidemiology, therapy and outcome of invasive mould infections in immunocompromised and/or immunosuppressed patients
    • PMid:20947312
    • Perkhofer S, Lass-Flor C, Hell M, Russ G, Krause R, Honigl M et al. The Nationwide Austrian Aspergillus Registry: a prospective data collection on epidemiology, therapy and outcome of invasive mould infections in immunocompromised and/or immunosuppressed patients. Int J Antimicr Ag 2010; 36:531-536 http://dx.doi.org/10.1016/j.ijantimicag.2010.08.010 PMid:20947312
    • (2010) Int J Antimicr Ag , vol.36 , pp. 531-536
    • Perkhofer, S.1    Lass-Flor, C.2    Hell, M.3    Russ, G.4    Krause, R.5    Honigl, M.6
  • 11
    • 84867336299 scopus 로고    scopus 로고
    • Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry
    • PMid:22898389
    • Steinbach WJ, Marr KA, Anaissie EJ, Azie N, Quan SP, Meier-Kriesche HU et al. Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry. J Infect 2012; 65:453-464 http://dx.doi.org/10.1016/j.jinf.2012.08.003 PMid:22898389
    • (2012) J Infect , vol.65 , pp. 453-464
    • Steinbach, W.J.1    Marr, K.A.2    Anaissie, E.J.3    Azie, N.4    Quan, S.P.5    Meier-Kriesche, H.U.6
  • 12
    • 24944503543 scopus 로고    scopus 로고
    • Multiple lines of chemotherapy are the main risk factor for severe infections in patients with chronic lymphocytic leukemia with febrile episodes
    • PMid:16079122
    • Molteni A, Nosari A, Montillo M, Cafro A, Klersy C, Morra E. Multiple lines of chemotherapy are the main risk factor for severe infections in patients with chronic lymphocytic leukemia with febrile episodes. Haematologica 2005; 90: 1145-1147 PMid:16079122
    • (2005) Haematologica , vol.90 , pp. 1145-1147
    • Molteni, A.1    Nosari, A.2    Montillo, M.3    Cafro, A.4    Klersy, C.5    Morra, E.6
  • 13
    • 0041660844 scopus 로고    scopus 로고
    • Disease activity and pre-treatment rather than ipogammaglobulinemia, are major risk factors for infectious complications in patients with chronic lymphocytic leukemia
    • PMid:12899715
    • Hensael M, Kornaker M, Yammeni S, Egerer G, Ho AD. Disease activity and pre-treatment rather than ipogammaglobulinemia, are major risk factors for infectious complications in patients with chronic lymphocytic leukemia. Br J Haematol 2003; 122: 600-606 http://dx.doi.org/10.1046/j.1365-2141.2003.04497.x PMid:12899715
    • (2003) Br J Haematol , vol.122 , pp. 600-606
    • Hensael, M.1    Kornaker, M.2    Yammeni, S.3    Egerer, G.4    Ho, A.D.5
  • 14
    • 2342436930 scopus 로고    scopus 로고
    • Pneumocystis carinii pneumonia in chronic lymphocytic leukemia
    • PMid:15082848, PMCid:1742966
    • Vavricka SR, Halter J, Hechelhammer L, Himmelmann A. Pneumocystis carinii pneumonia in chronic lymphocytic leukemia. Postgrad Med J 2004; 80 :236-238 http://dx.doi.org/10.1136/pgmj.2003.012252 PMid:15082848 PMCid:1742966
    • (2004) Postgrad Med J , vol.80 , pp. 236-238
    • Vavricka, S.R.1    Halter, J.2    Hechelhammer, L.3    Himmelmann, A.4
  • 15
    • 22044443115 scopus 로고    scopus 로고
    • Extrapulmonary tuberculous abscess in chronic lymphocytic leukemia treated with fludarabine: case report and review of literature
    • PMid:15981223
    • Leung WH, Tsang SF, Chim CS. Extrapulmonary tuberculous abscess in chronic lymphocytic leukemia treated with fludarabine: case report and review of literature. Am J Hematol 2005; 79: 246-247 http://dx.doi.org/10.1002/ajh.20322 PMid:15981223
    • (2005) Am J Hematol , vol.79 , pp. 246-247
    • Leung, W.H.1    Tsang, S.F.2    Chim, C.S.3
  • 16
    • 0026744046 scopus 로고
    • Infections and serum IgG levels in patients with chronic lymphocytic leukemia
    • PMid:1644158
    • Itola M, Helenius H, Nikoskelaien J and Remes K. Infections and serum IgG levels in patients with chronic lymphocytic leukemia. Eur J Haematol 1992; 48 266-270. PMid:1644158
    • (1992) Eur J Haematol , vol.48 , pp. 266-270
    • Itola, M.1    Helenius, H.2    Nikoskelaien, J.3    Remes, K.4
  • 17
    • 58149243238 scopus 로고    scopus 로고
    • Serum globulins as marker of immune restoration after treatment with high-dose rituximab for chronic lymphocytic leukemia
    • PMid:18176848
    • Alexandrescu DT, Wiernik PH. Serum globulins as marker of immune restoration after treatment with high-dose rituximab for chronic lymphocytic leukemia. Med Oncol 2008; 25: 309-314 http://dx.doi.org/10.1007/s12032-007-9037-8 PMid:18176848
    • (2008) Med Oncol , vol.25 , pp. 309-314
    • Alexandrescu, D.T.1    Wiernik, P.H.2
  • 18
    • 0027979004 scopus 로고
    • Immunoglobulin replacement in patients with chronic lymphocytic leukaemia a comparison of two dose regimens
    • PMid:7803248
    • Chapel H, Dicato M, Gamm H, Brennan V, Ries F, Bunch C and Lee M. Immunoglobulin replacement in patients with chronic lymphocytic leukaemia a comparison of two dose regimens. Br J Haematol 1994; 88 209-212. http://dx.doi.org/10.1111/j.1365-2141.1994.tb05002.x PMid:7803248
    • (1994) Br J Haematol , vol.88 , pp. 209-212
    • Chapel, H.1    Dicato, M.2    Gamm, H.3    Brennan, V.4    Ries, F.5    Bunch, C.6    Lee, M.7
  • 20
    • 0019934873 scopus 로고
    • Abonormal T-lymphocyte subpopolations in patients with B cell chronic lymphocytic leukemia an analysis by monoclonal antibodies
    • PMid:6214590
    • Platsoucas CD, Galinski M, Kempin S, Reich L, Clarkcon B and Good RA. Abonormal T-lymphocyte subpopolations in patients with B cell chronic lymphocytic leukemia an analysis by monoclonal antibodies. J Immunol 1982; 129 2305-2312 PMid:6214590
    • (1982) J Immunol , vol.129 , pp. 2305-2312
    • Platsoucas, C.D.1    Galinski, M.2    Kempin, S.3    Reich, L.4    Clarkcon, B.5    Good, R.A.6
  • 21
    • 0029901196 scopus 로고    scopus 로고
    • Functional abnormalities in granulocytes predict susceptibility to bacterial infections in chronic lymphocitic leukemia
    • Itala M, Vainio O, Remes K. Functional abnormalities in granulocytes predict susceptibility to bacterial infections in chronic lymphocitic leukemia. Eur J Haematol 1996; 57: 46-53 http://dx.doi.org/10.1111/j.1600-0609.1996.tb00489.x
    • (1996) Eur J Haematol , vol.57 , pp. 46-53
    • Itala, M.1    Vainio, O.2    Remes, K.3
  • 22
    • 0018354333 scopus 로고
    • Monocyte and granulocyte defect in chronic lymphocytic leukemia
    • PMid:219699, PMCid:2042293
    • Zeya HI, Keku E, Richards F and Spurr CL. Monocyte and granulocyte defect in chronic lymphocytic leukemia. Am J Pathol 1979; 95 43-54 PMid:219699 PMCid:2042293
    • (1979) Am J Pathol , vol.95 , pp. 43-54
    • Zeya, H.I.1    Keku, E.2    Richards, F.3    Spurr, C.L.4
  • 23
    • 0021949085 scopus 로고
    • Defective complement activity in CLL
    • PMid:3845763
    • Heath M, Cheson BD. Defective complement activity in CLL. Am J Hematol 1985; 19: 63-73 http://dx.doi.org/10.1002/ajh.2830190109 PMid:3845763
    • (1985) Am J Hematol , vol.19 , pp. 63-73
    • Heath, M.1    Cheson, B.D.2
  • 24
    • 0028333904 scopus 로고
    • The management of chronic lymphocytic leukemia at a single centre over a 24 year period prognostic factors for survival
    • PMid:7515019
    • Karmiris T, Rohatiner AZ, Love S, Carter M, Ganjoo RK, Amess J, Norton AJ, Lister TA. The management of chronic lymphocytic leukemia at a single centre over a 24 year period prognostic factors for survival. Haematol Oncol 1994; 12 (1) 29-39 http://dx.doi.org/10.1002/hon.2900120105 PMid:7515019
    • (1994) Haematol Oncol , vol.12 , Issue.1 , pp. 29-39
    • Karmiris, T.1    Rohatiner, A.Z.2    Love, S.3    Carter, M.4    Ganjoo, R.K.5    Amess, J.6    Norton, A.J.7    Lister, T.A.8
  • 25
    • 0035880884 scopus 로고    scopus 로고
    • Impact of therapy with chlorambucil, fludarabine or fludarabine plus chlorambucil on infections in patients with chronic lymphocitic leukemia: Intergroup Study Cancer and Leukemia Group B 9011
    • PMid:11504743
    • Morrison VA, Rai K, Peterson BL, Kolitz JE, Elias L, Appelbaum FR, Hines JD, Shepherd L, Martell RE, Larson RA, Schiffer CA. Impact of therapy with chlorambucil, fludarabine or fludarabine plus chlorambucil on infections in patients with chronic lymphocitic leukemia: Intergroup Study Cancer and Leukemia Group B 9011. J Clin Oncol 2001; 19: 3611-3621 PMid:11504743
    • (2001) J Clin Oncol , vol.19 , pp. 3611-3621
    • Morrison, V.A.1    Rai, K.2    Peterson, B.L.3    Kolitz, J.E.4    Elias, L.5    Appelbaum, F.R.6    Hines, J.D.7    Shepherd, L.8    Martell, R.E.9    Larson, R.A.10    Schiffer, C.A.11
  • 29
    • 0033771581 scopus 로고    scopus 로고
    • Mycobacterium genavense infection in a patient with long-standing chronic lymphocytic leukemia
    • PMid:11086646
    • Krebs T, Zimmerli S, Bodmer T, Lammle B. Mycobacterium genavense infection in a patient with long-standing chronic lymphocytic leukemia. J Intern Med 2000; 248: 343-348 http://dx.doi.org/10.1046/j.1365-2796.2000.00730.x PMid:11086646
    • (2000) J Intern Med , vol.248 , pp. 343-348
    • Krebs, T.1    Zimmerli, S.2    Bodmer, T.3    Lammle, B.4
  • 30
    • 27144548424 scopus 로고    scopus 로고
    • Efficacy of bendamustine in patients with relapsed or refractory chronic limphocytic leukemia: results of a phase I/II study of the German CLL Study Group
    • PMid:16219572
    • Bergmann M, Goebeler ME, Herold M, Emmerich B, Wilhelm M, Ruelfs C, Boening L, Hallek MJ. Efficacy of bendamustine in patients with relapsed or refractory chronic limphocytic leukemia: results of a phase I/II study of the German CLL Study Group. Haematologica 2005; 90: 1357-1364 PMid:16219572
    • (2005) Haematologica , vol.90 , pp. 1357-1364
    • Bergmann, M.1    Goebeler, M.E.2    Herold, M.3    Emmerich, B.4    Wilhelm, M.5    Ruelfs, C.6    Boening, L.7    Hallek, M.J.8
  • 32
    • 0028999305 scopus 로고
    • Opportunistic pulmonary infections with fludarabine in previously treated patients with low-grade lymphoid malignancies A role for Pneumocystis carinii pneumonia prophylaxis
    • PMid:7771465
    • Byrd JC, Hargis JB, Kester KE, Hospenthal DR, Knutson SW and Diehl LF. Opportunistic pulmonary infections with fludarabine in previously treated patients with low-grade lymphoid malignancies A role for Pneumocystis carinii pneumonia prophylaxis. Am J Hematol 1995; 49 135-145 http://dx.doi.org/10.1002/ajh.2830490207 PMid:7771465
    • (1995) Am J Hematol , vol.49 , pp. 135-145
    • Byrd, J.C.1    Hargis, J.B.2    Kester, K.E.3    Hospenthal, D.R.4    Knutson, S.W.5    Diehl, L.F.6
  • 35
    • 33947541773 scopus 로고    scopus 로고
    • Phase III trial of of fludarabine plus cyclophosphamide compared with fludarabine for patients with previously untreated chronic lymphocytic leukemia: US Intergroup Trial E29976
    • PMid:17283364
    • Flinn IW, Neuberg DS, Grever MR, Dewald GW, BennetJM, Paietta EM, Hussein MA, Appelbaum FR, Larson RA, Mooore DF, Tallman MS. Phase III trial of of fludarabine plus cyclophosphamide compared with fludarabine for patients with previously untreated chronic lymphocytic leukemia: US Intergroup Trial E29976. J Clin Oncol 2007; 25: 793-798 http://dx.doi.org/10.1200/JCO.2006.08.0762 PMid:17283364
    • (2007) J Clin Oncol , vol.25 , pp. 793-798
    • Flinn, I.W.1    Neuberg, D.S.2    Grever, M.R.3    Dewald, G.W.4    Bennet, J.M.5    Paietta, E.M.6    Hussein, M.A.7    Appelbaum, F.R.8    Larson, R.A.9    Mooore, D.F.10    Tallman, M.S.11
  • 36
    • 0035282055 scopus 로고    scopus 로고
    • Results of the fludarabine and cyclophosphamide combination regimen in chronic lymphocytic leukemia
    • PMid:11230486
    • O' Brien S, Kantarjian HM, Cortes J, Beran M, Koller C, Giles FJ, lerner S, keating M. Results of the fludarabine and cyclophosphamide combination regimen in chronic lymphocytic leukemia. J Clin Oncol 2001; 19: 1414-1420 PMid:11230486
    • (2001) J Clin Oncol , vol.19 , pp. 1414-1420
    • O'Brien, S.1    Kantarjian, H.M.2    Cortes, J.3    Beran, M.4    Koller, C.5    Giles, F.J.6    Lerner, S.7    Keating, M.8
  • 38
    • 0036839469 scopus 로고    scopus 로고
    • Phase 2 study of a combined immunochemotherapy using rituximab and fludarabine in patients with chronic lymphocytic leukemia
    • PMid:12384407
    • Shulz H, Klein SK, Rehwald U, Reiser M, Hinke A, Knauf WU, et al. Phase 2 study of a combined immunochemotherapy using rituximab and fludarabine in patients with chronic lymphocytic leukemia. Blood 2002; 100:3115-3120 http://dx.doi.org/10.1182/blood-2002-03-0972 PMid:12384407
    • (2002) Blood , vol.100 , pp. 3115-3120
    • Shulz, H.1    Klein, S.K.2    Rehwald, U.3    Reiser, M.4    Hinke, A.5    Knauf, W.U.6
  • 41
    • 81255129068 scopus 로고    scopus 로고
    • Progressive multifocal leukoencephalopathy: an unespected complication of modern therapeutic monoclonal antibody teraphies
    • PMid:22082208
    • Tavazzi E, Ferrante P, Khalili K. Progressive multifocal leukoencephalopathy: an unespected complication of modern therapeutic monoclonal antibody teraphies. Clin Microbiol Infect 2011; 17: 1776-1780 http://dx.doi.org/10.1111/j.1469-0691.2011.03653.x PMid:22082208
    • (2011) Clin Microbiol Infect , vol.17 , pp. 1776-1780
    • Tavazzi, E.1    Ferrante, P.2    Khalili, K.3
  • 42
    • 10444276466 scopus 로고    scopus 로고
    • Infectious toxicity using alemtuzumab
    • PMid:15590388
    • Nosari A, Montillo M, Morra E. Infectious toxicity using alemtuzumab. Haematologica 2004; 89: 1415-1419 PMid:15590388
    • (2004) Haematologica , vol.89 , pp. 1415-1419
    • Nosari, A.1    Montillo, M.2    Morra, E.3
  • 43
    • 37649004407 scopus 로고    scopus 로고
    • Alemtuzumab compared with chlorambucil as first-line therapy for chronic lymphocytic leukemia
    • PMid:17984186
    • Hillmen P, Skotnicki AB, Robak T, Jaksic B, Dmoszynska A, Wu J, Sirard C, Mayer J. Alemtuzumab compared with chlorambucil as first-line therapy for chronic lymphocytic leukemia. J Clin Oncol 2007; 25: 5616-5623 http://dx.doi.org/10.1200/JCO.2007.12.9098 PMid:17984186
    • (2007) J Clin Oncol , vol.25 , pp. 5616-5623
    • Hillmen, P.1    Skotnicki, A.B.2    Robak, T.3    Jaksic, B.4    Dmoszynska, A.5    Wu, J.6    Sirard, C.7    Mayer, J.8
  • 44
    • 40849100404 scopus 로고    scopus 로고
    • Characteristics and stage of the underlying diseases could determine the risk of opportunistic infections in patients receiving alemtuzumab
    • PMid:18245646
    • Nosari A, Tedeschi A, RicciF, Montillo M. Characteristics and stage of the underlying diseases could determine the risk of opportunistic infections in patients receiving alemtuzumab. Haematologica 2008; 93: e30-31 http://dx.doi.org/10.3324/haematol.12465 PMid:18245646
    • (2008) Haematologica , vol.93
    • Nosari, A.1    Tedeschi, A.2    Ricci, F.3    Montillo, M.4
  • 45
    • 0029937765 scopus 로고    scopus 로고
    • Humanized CD52 monoclonal antibody Campath-1H as line treatment in chronic lymphocytic leukemia
    • Mellstedt H for the European Study Group of Campath-1H treatment in CLL.
    • Osterborg A, Dyer MJS, Bunjes D, Pangalis GA, Bastion Y, Catovsky D, Mellstedt H for the European Study Group of Campath-1H treatment in CLL. Humanized CD52 monoclonal antibody Campath-1H as line treatment in chronic lymphocytic leukemia. Br J Haematol 1996; 93: 151-153 http://dx.doi.org/10.1046/j.1365-2141.1996.450989.x
    • (1996) Br J Haematol , vol.93 , pp. 151-153
    • Osterborg, A.1    Dyer, M.J.S.2    Bunjes, D.3    Pangalis, G.A.4    Bastion, Y.5    Catovsky, D.6
  • 46
    • 0037092951 scopus 로고    scopus 로고
    • Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study
    • PMid:11986207
    • Keating MJ, Flinn I, Vinay J, Binet JL, Hillmen P, Byrd J, Albitar M, Brettman L, Santabarbara P, Wacker B, Rai KR. Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study. Blood 2002; 99: 3554-3561 http://dx.doi.org/10.1182/blood.V99.10.3554 PMid:11986207
    • (2002) Blood , vol.99 , pp. 3554-3561
    • Keating, M.J.1    Flinn, I.2    Vinay, J.3    Binet, J.L.4    Hillmen, P.5    Byrd, J.6    Albitar, M.7    Brettman, L.8    Santabarbara, P.9    Wacker, B.10    Rai, K.R.11
  • 50
    • 79959840618 scopus 로고    scopus 로고
    • Alemtuzumab:what is the secret to safe therapy?
    • PMid:21685865
    • Elter T, Hallek M, Montillo M. Alemtuzumab:what is the secret to safe therapy?. Clin Adv Hematol Oncol 2011;9:364-373 PMid:21685865
    • (2011) Clin Adv Hematol Oncol , vol.9 , pp. 364-373
    • Elter, T.1    Hallek, M.2    Montillo, M.3
  • 51
    • 84875991863 scopus 로고    scopus 로고
    • Polish Lymphoma Research Group Web site Geisler C. HOVO68 CLL protocol: annual safety report PMid:20194866
    • Polish Lymphoma Research Group Web site Geisler C. HOVO68 CLL protocol: annual safety report 2008. http.//www.plrg.pl/images/stories/badania/hovon/HOVON68CLL_Annual_Safety_Report_2008.pdf PMid:20194866
    • (2008)
  • 52
    • 77950502126 scopus 로고    scopus 로고
    • Ofatumumab as single agent CD20 immunotherapy in fludarabine-refractory chronic lymphocytic leukemia
    • PMid:16618945
    • Wierda WG, Kipps TJ, Mayer J, Stilgenbauer S, Williams CD, Hellmann A, et al. Ofatumumab as single agent CD20 immunotherapy in fludarabine-refractory chronic lymphocytic leukemia. J Clin Oncol 2010;28: 1749-1755 http://dx.doi.org/10.1200/JCO.2009.25.3187 PMid:16618945
    • (2010) J Clin Oncol , vol.8 , pp. 1749-1755
    • Wierda, W.G.1    Kipps, T.J.2    Mayer, J.3    Stilgenbauer, S.4    Williams, C.D.5    Hellmann, A.6
  • 53
    • 33744793781 scopus 로고    scopus 로고
    • Alemtuzumab as consolidation after a response to fludarabine is effective in purging residual disease in patients with chronic lymphocytic leukemia
    • PMid:20697069 PMCid:2988639
    • Montillo M, Tedeschi A, Miqueleiz S, Veronese S, Intropido L, Ricci F, Colosimo A, Scarpati B, Montagna M, Nichelatti M, Regazzi M, Morra E. Alemtuzumab as consolidation after a response to fludarabine is effective in purging residual disease in patients with chronic lymphocytic leukemia. J Clin Oncol 2006; 24: 2337-2342 http://dx.doi.org/10.1200/JCO.2005.04.6037 PMid:20697069 PMCid:2988639
    • (2006) J Clin Oncol , vol.24 , pp. 2337-2342
    • Montillo, M.1    Tedeschi, A.2    Miqueleiz, S.3    Veronese, S.4    Intropido, L.5    Ricci, F.6    Colosimo, A.7    Scarpati, B.8    Montagna, M.9    Nichelatti, M.10    Regazzi, M.11    Morra, E.12
  • 54
    • 78650017999 scopus 로고    scopus 로고
    • Consolidation therapy with subcutaneous alemtuzumab after fludarabine and rituximab induction therapy for previously untreated chronic lymphocytic leukemia: final analysis of CALGB 10101
    • PMid:21670470
    • Lin TS, Donohue K A, Byrd JC, Lucas MS, Hoke EE, Bengtson EM, Rai KR, Atkins JN, Link BK, Larson RA. Consolidation therapy with subcutaneous alemtuzumab after fludarabine and rituximab induction therapy for previously untreated chronic lymphocytic leukemia: final analysis of CALGB 10101. J Clin Oncol 2010; 28: 4500-4506 http://dx.doi.org/10.1200/JCO.2010.29.7978 PMid:21670470
    • (2010) J Clin Oncol , vol.28 , pp. 4500-4506
    • Lin, T.S.1    Donohue, K.A.2    Byrd, J.C.3    Lucas, M.S.4    Hoke, E.E.5    Bengtson, E.M.6    Rai, K.R.7    Atkins, J.N.8    Link, B.K.9    Larson, R.A.10
  • 55
    • 80052188111 scopus 로고    scopus 로고
    • Cyclophosphamide, fludarabine, alemtuzumab and rituximab as salvage therapy for heavily pretreated patients with chronic lymphocytic leukemia
    • PMid:23090186 PMCid:3478266
    • Badoux XC, Keating MJ, Wang X, O' Brien S, Ferrajoli A, Faderl S, Burger J, Koller C, Lerner S, Kantarjian H, Wierda WG. Cyclophosphamide, fludarabine, alemtuzumab and rituximab as salvage therapy for heavily pretreated patients with chronic lymphocytic leukemia. Blood 2011; 118: 2085-2093 http://dx.doi.org/10.1182/blood-2011-03-341032 PMid:23090186 PMCid:3478266
    • (2011) Blood , vol.118 , pp. 2085-2093
    • Badoux, X.C.1    Keating, M.J.2    Wang, X.3    O'Brien, S.4    Ferrajoli, A.5    Faderl, S.6    Burger, J.7    Koller, C.8    Lerner, S.9    Kantarjian, H.10    Wierda, W.G.11
  • 56
    • 35148849255 scopus 로고    scopus 로고
    • The natural history of fludarabine-refractory chronic lymphocytic leukemia patients who failed alemtuzumab or have bulky adenopathy
    • PMid:21498674
    • Tam CS, O' Brien S, Lerner S, Khouri I, Ferrajoli A, Faderl S, Browning M, Tsimberidou AM, Kantarjian H, Wierda WG. The natural history of fludarabine-refractory chronic lymphocytic leukemia patients who failed alemtuzumab or have bulky adenopathy. Leuk Lymph 2007; 48:1931-1939 http://dx.doi.org/10.1080/10428190701573257 PMid:21498674
    • (2007) Leuk Lymph , vol.48 , pp. 1931-1939
    • Tam, C.S.1    O'Brien, S.2    Lerner, S.3    Khouri, I.4    Ferrajoli, A.5    Faderl, S.6    Browning, M.7    Tsimberidou, A.M.8    Kantarjian, H.9    Wierda, W.G.10
  • 58
    • 0032189459 scopus 로고    scopus 로고
    • Infections in patients with chronic lymphocytic leukemia: pathogenesis, spectrum of infection, and approach to prophylaxis
    • PMid:3317855
    • Anaissie E, Kontoyiannis DP, O' Brien S, Kantarjian H, Robertson L, Lerner S, Keating M. Infections in patients with chronic lymphocytic leukemia: pathogenesis, spectrum of infection, and approach to prophylaxis. Ann Intern Med 1998; 129:559-566 PMid:3317855
    • (1998) Ann Intern Med , vol.129 , pp. 559-566
    • Anaissie, E.1    Kontoyiannis, D.P.2    O'Brien, S.3    Kantarjian, H.4    Robertson, L.5    Lerner, S.6    Keating, M.7
  • 59
    • 0023428147 scopus 로고
    • mechanisms of infection inchronic lymphocytic leukemia
    • PMid:2901668
    • Chapel HM and Bunch C. mechanisms of infection inchronic lymphocytic leukemia. Semin Hematol 1987; 24 291-296 PMid:2901668
    • (1987) Semin Hematol , vol.24 , pp. 291-296
    • Chapel, H.M.1    Bunch, C.2
  • 60
    • 0023764718 scopus 로고
    • Intravenous immunoglobulin for the prevention of infection in chronic lymphocytic leukemia
    • Cooperative Group for the Study of Immunoglobulin in Chronic Lymphocytic Leukemia, PMid:12651283
    • Cooperative Group for the Study of Immunoglobulin in Chronic Lymphocytic Leukemia. Intravenous immunoglobulin for the prevention of infection in chronic lymphocytic leukemia. N Engl J Med 1988; 319: 902-907 http://dx.doi.org/10.1056/NEJM198810063191403 PMid:12651283
    • (1988) N Engl J Med , vol.319 , pp. 902-907
  • 62
    • 0001736301 scopus 로고
    • Antibody response to pneumococcal immunization in patients with chronic lymphocytic leukemia
    • Jacobson DR, Ballard HS, Silber R, Ripps CS, Smith JA and Schiffman GS. Antibody response to pneumococcal immunization in patients with chronic lymphocytic leukemia. Blood 1988; 72 (suppl 1): 205a
    • (1988) Blood , vol.72 , Issue.SUPPL. 1 , pp. 205
    • Jacobson, D.R.1    Ballard, H.S.2    Silber, R.3    Ripps, C.S.4    Smith, J.A.5    Schiffman, G.S.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.